IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2003;44:3282-3287.)
© 2003 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0081
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergman, L.
Right arrow Articles by Ragnarsson-Olding, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergman, L.
Right arrow Articles by Ragnarsson-Olding, B.

Uveal Melanoma Survival in Sweden from 1960 to 1998

Louise Bergman,1 Stefan Seregard,1 Bo Nilsson,2 Göran Lundell,2 Ulrik Ringborg,2 and Boel Ragnarsson-Olding2

1From the St. Erik’s Eye Hospital and 2Department of General Oncology, Radiumhemmet, Karolinska Hospital, Stockholm, Sweden.

PURPOSE. To investigate the crude and relative survival rates in patients with uveal melanoma in Sweden during the period from 1960 to 1998.

METHODS. A population-based national survey revealed 2997 cases of uveal melanoma in the Swedish Cancer Registry. The survival rates were calculated by the Hakulinen life-table method, using relative survival as an estimate for deaths due to uveal melanoma. The excess mortality rates were calculated with confidence intervals for the first 15 years after diagnosis. Multivariate regression analysis was undertaken to evaluate the influence of gender, age, and calendar period on relative survival the first 5 years after diagnosis. The underlying causes of deaths in the patients with uveal melanoma, as found in the Cause of Death Registry were also investigated.

RESULTS. Up to December 31, 1998, 2003 patients had died. The 5-year crude survival rate was 60.3% and the relative survival 70.1%. After 10 years, the rates were 42.5% and 59.4%, respectively. Significant excess mortality existed up to 5.5 years after diagnosis. In the multivariate model, younger age (P < 0.001) and later calendar period (P = 0.002), but not gender (P = 0.117), were associated with better relative survival. Deaths due to uveal melanoma were misclassified in the Cause of Death Registry in more than half of the cases.

CONCLUSIONS. This study, covering more than 95% of the uveal melanoma cases in the Swedish population revealed an improvement in relative survival rates for patients with uveal melanoma over time and a significant excess mortality up to 5.5 years after diagnosis.




This article has been cited by other articles:


Home page
 IOVSHome page
W. Maat, L. V. Ly, E. S. Jordanova, D. de Wolff-Rouendaal, N. E. Schalij-Delfos, and M. J. Jager
Monosomy of Chromosome 3 and an Inflammatory Phenotype Occur Together in Uveal Melanoma
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 505 - 510.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Sandinha, M. Farquharson, I. McKay, and F. Roberts
Correlation of Heterogeneity for Chromosome 3 Copy Number with Cell Type in Choroidal Melanoma of Mixed-Cell Type
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5177 - 5180.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. A. Economou, C. All-Ericsson, V. Bykov, L. Girnita, A. Bartolazzi, O. Larsson, and S. Seregard
Receptors for the Liver Synthesized Growth Factors IGF-1 and HGF/SF in Uveal Melanoma: Intercorrelation and Prognostic Implications
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4372 - 4375.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. T. Sandinha, M. A. Farquharson, I. C. McKay, and F. Roberts
Monosomy 3 Predicts Death but Not Time until Death in Choroidal Melanoma
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3497 - 3501.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M T Sandinha, M A Farquharson, and F Roberts
Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation
Br. J. Ophthalmol., December 1, 2004; 88(12): 1527 - 1532.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
A D Singh, I G Rennie, T Kivela, S Seregard, and H Grossniklaus
The Zimmerman-McLean-Foster hypothesis: 25 years later
Br. J. Ophthalmol., July 1, 2004; 88(7): 962 - 967.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Association for Research in Vision and Ophthalmology